Target Audience: This broadcast is targeted at gastroenterologists, rheumatologists, primary care physicians, nurse practitioners (NPs), physician assistants (PAs), nurses and clinical pharmacists (PharmD).

Educational Objectives:

After completing this program, participants should be better able to:

  • Summarize the regulatory definition of biosimilars and their requirements for approval in the United States
  • Compare biologics with their reference products and with small molecule generic therapies
  • Discuss how considerations for interchangeability and extrapolation of clinical data across indications impact their incorporation into clinical practice
  • Proactively educate patients regarding biosimilar options and engage them in the decision-making process

ACCME Accreditation:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Annenberg Center for Health Sciences at Eisenhower (ACHS), Gi Health Foundation (GiHF), Annual Rheumatology and Therapeutics Review for Organizations and Societies (ARTHROS), Gastroenterology & Hepatology Advanced Practice Providers (GHAPP) and Rheumatology Advanced Practice Providers (RHAPP). The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

ACHS designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AANP Accreditation:

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of the ACHS, GiHF, ARTHROS, GHAPP, and RhAPP. The ACHS is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number 040207

This activity is approved for 1.0 contact hour. Program ID #5885.

AAPA Accreditation:

This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid from 3/19/2021 to 3/19/2022. PAs should only claim credit commensurate with the extent of their participation. AAPA reference number: CME-202023.

ACPE Accreditation:

The ACHS is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program has been assigned ACPE Universal Program # 0797-9999-21-001-L01-P. This program is designated for up to 1.0 contact hours (1.0 CEU) of continuing pharmacy education credit.

Disclosure of Conflicts of Interest:

All individuals in control of the content of continuing education activities provided by the ACHS are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. All staff at the ACHS, GiHF, ARTHROS, GHAPP, and RhAPP here have no relationships to disclose.

Learner Assurance Statement:

The ACHS is committed to mitigating all conflict of interest issues that could arise as a result of individuals who control activity content and who have relationships with ACCME-defined ineligible companies. The ACHS is committed to retaining only those individuals with financial interests that can be reconciled with the goals and educational integrity of the CME activity.

Jointly provided by Annenberg Center for Health Sciences at Eisenhower, Gi Health Foundation, Annual Rheumatology and Therapeutics Review for Organizations and Societies, Gastroenterology & Hepatology Advanced Practice Providers and Rheumatology Advanced Practice Providers.

Jointly Provided by

Supported by an educational grant from Pfizer, Inc.